Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Effects of Ketogenic Diet on Alcohol Intoxication
for
Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder,
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 21 - 50
Code: NCT07602270
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: Boston MA, Philadelphia PA, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase 1, Recruiting
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Location: Portland ME, Philadelphia PA, Pittsburgh PA,
Sponsor: University of Michigan
Sex: All
Age: 70+
Code: NCT05929703
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for
Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,
Location: Philadelphia PA, Atlanta GA, Grand Rapids MI,
Sponsor: Scholar Rock, Inc.
Sex: All
Age: 0 - 2
Code: NCT07047144
Phase 2, Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Rimouski, Boston MA, Worcester MA, Hartford CT, Quebec,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
for
Chronic Kidney Disease Requiring Hemodialysis
Location: Pittsburgh PA, Albuquerque NM
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT06978127
Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Farmington CT, Brooklyn NY, Staten Island NY, Media PA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18+
Code: NCT06701903
Phase 2, Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for
Aortic Arch Dissection, Aortic Arch Aneurysm
Location: Boston MA, Hartford CT, Philadelphia PA, Baltimore MD,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07166133
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 40+
Code: NCT07201922
Phase 3, Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA, Miami FL,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase 2, Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Shirley NY, Westbury NY, New York NY, Greenfield Park,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
for
Chronic Lung Disease, Pulmonary Hypertension
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 18 - 70+
Code: NCT07151768
Recruiting
Mental Health Clinician / Chaplain Collaboration
for
Moral Injury
Location: Pittsburgh PA
Sponsor: Central Arkansas Veterans Healthcare System
Sex: All
Age: 18 - 70+
Code: NCT07579143
Recruiting
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
for
Pulmonary Hypertension
Location: Providence RI, Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT07132788
Recruiting
CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy
for
Chemotherapy-Induced Peripheral Neuropathy
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 21+
Code: NCT07016971
Phase 1, Recruiting
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Manahawkin NJ, Fairfax VA, Weston FL, Pittsburgh PA,
Sponsor: Wayshine Biopharm, Inc.
Sex: All
Age: 18+
Code: NCT06868485
Phase 2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma